Start-up
Tcelltech GmbH
About Tcelltech
Tcelltech GmbH, a spin-out of the German Cancer Research Center (DKFZ), develops a universal personalised adoptive cell therapy against all cancers (UNIPACT).
UNIPACT is based on two platform technologies:
(I) a high-performance gene expression DNA vector platform (nanoSMAR)
(II) an AI bioinformatics platform which identifies reactive T cell receptors (selecTCR).
Facts about Tcelltech
Facts about Tcelltech
- Founding: 2022
- Focus : Manufacturer
- Employees: 1-10
- Industry : Biotechnology, Pharma
